-
Loading metrics
Open Access
Peer-reviewed
Research Article
Lestaurtinib is a potent inhibitor of anaplastic thyroid cancer cell line models
-
Nicole Pinto,
Roles Conceptualization, Data curation, Formal analysis, Investigation, Methodology, Validation, Writing – original draft, Writing – review & editing
Affiliations Department of Otolaryngology—Head and Neck Surgery, Western University, London, Ontario, Canada, Department of Anatomy and Cell Biology, Western University, London, Ontario, Canada
⨯ -
Stephenie D. Prokopec,
Roles Formal analysis, Writing – review & editing
Affiliation Ontario Institute for Cancer Research, Toronto, Ontario, Canada
⨯ -
Frederick Vizeacoumar,
Roles Resources
Affiliation Cancer Research Cluster, University of Saskatchewan, Saskatchewan, Canada
⨯ - Karlee Searle,
-
Matthew Lowerison,
Roles Data curation
Affiliation Department of Medical Biophysics, Western University, London, Ontario, Canada
⨯ -
Kara M. Ruicci,
Roles Writing – review & editing
Affiliation Department of Otolaryngology—Head and Neck Surgery, Western University, London, Ontario, Canada
⨯ -
John Yoo,
Roles Writing – review & editing
Affiliation Department of Otolaryngology—Head and Neck Surgery, Western University, London, Ontario, Canada
⨯ -
Kevin Fung,
Roles Writing – review & editing
Affiliation Department of Otolaryngology—Head and Neck Surgery, Western University, London, Ontario, Canada
⨯ -
Danielle MacNeil,
Roles Writing – review & editing
Affiliation Department of Otolaryngology—Head and Neck Surgery, Western University, London, Ontario, Canada
⨯ -
Jim C. Lacefield,
Roles Resources, Writing – review & editing
Affiliation Department of Medical Biophysics, Western University, London, Ontario, Canada
⨯ -
Hon S. Leong,
Roles Resources
Affiliation Department of Urology, Mayo Clinic, Rochester, Minnesota, United States of America
⨯ -
Joe S. Mymryk,
Roles Resources, Writing – review & editing
Affiliations Department of Oncology, Western University, London, Ontario, Canada, Department of Microbiology and Immunology, Western University, London, Ontario, Canada
⨯ -
John W. Barrett,
Roles Conceptualization, Supervision, Writing – review & editing
Affiliations Department of Otolaryngology—Head and Neck Surgery, Western University, London, Ontario, Canada, Department of Oncology, Western University, London, Ontario, Canada
⨯ -
Alessandro Datti,
Roles Resources, Writing – review & editing
Affiliations Network Biology Collaborative Centre, Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada, Department of Agricultural, Food, and Environmental Sciences, University of Perugia, Perugia, Italy
⨯ -
Paul C. Boutros ,
Contributed equally to this work with: Paul C. Boutros, Anthony C. Nichols
Roles Resources, Software, Writing – review & editing
Affiliations Ontario Institute for Cancer Research, Toronto, Ontario, Canada, Department of Medical Biophysics, University of Toronto, Toronto, Ontario, Canada, Department of Pharmacology & Toxicology, University of Toronto, Toronto, Ontario, Canada
⨯ - [ ... ],
-
Anthony C. Nichols
Contributed equally to this work with: Paul C. Boutros, Anthony C. Nichols
Roles Conceptualization, Funding acquisition, Supervision, Writing – review & editing
* E-mail: Anthony.Nichols@lhsc.on.ca
Affiliations Department of Otolaryngology—Head and Neck Surgery, Western University, London, Ontario, Canada, Department of Oncology, Western University, London, Ontario, Canada
⨯ - [ view all ]
- [ view less ]
Lestaurtinib is a potent inhibitor of anaplastic thyroid cancer cell line models
- Nicole Pinto,
- Stephenie D. Prokopec,
- Frederick Vizeacoumar,
- Karlee Searle,
- Matthew Lowerison,
- Kara M. Ruicci,
- John Yoo,
- Kevin Fung,
- Danielle MacNeil,
- Jim C. Lacefield
- Published: November 12, 2018
- https://doi.org/10.1371/journal.pone.0207152